Cancer Research The Future of Cancer Research: Science and Patient Impact  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 324-330, January 15, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Djurhuus, R.
Right arrow Articles by Ueland, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Djurhuus, R.
Right arrow Articles by Ueland, P. M.

Differential Effects on Growth, Homocysteine, and Related Compounds of Two Inhibitors of S-Adenosylhomocysteine Catabolism, 3-Deazaadenosine, and 3-Deazaaristeromycin, in C3H/10T1/2 Cells1

Rune Djurhuus2, Asbjørn M. Svardal3 and Per M. Ueland

Clinical Pharmacology Unit, Department of Pharmacology and Toxicology, University of Bergen, Norway

The growth of nontransformed (Cl 8) and malignant (Cl 16) C3H/10T1/2 mouse embryo fibroblasts was inhibited by 3-deazaadenosine (c3Ado) (LD50 = 195 µM for CI 8 and 30 µM for CI 16 cells) and 3-deazaaristeromycin (c3Ari) (LD50 about 36 µM for CI 8 and 9 µM for CI 16 cells). Both compounds inhibited in a dose-dependent manner S-adenosylhomocysteine (AdoHcy) catabolism and homocysteine production, measured as homocysteine egress, and c3Ari was most potent in this respect. c3Ado gave rise to its congener, 3-deazaadenosylhomocysteine (c3AdoHcy). Addition of homocysteine thiolactone (Hcy-tl) to the medium enhanced AdoHcy (and c3AdoHcy) accumulation but did not affect the cell growth at concentrations of inhibitor less than 10 µM. At high concentrations (30–300 µM) both compounds were cytotoxic and decreased cell count when added during midexponential growth. When Hcy-tl was supplemented under these conditions it partly rescued the malignant cells exposed to c3Ari, did not affect the cytotoxicity of this agent towards the nontransformed cells, but greatly potentiated the cytotoxicity of c3Ado against both cell types. Differential metabolic effects were also observed in that high concentrations of c3Ado, but not c3Ari, induced build-up of c3AdoHcy and modulated cellular glutathione level. Growing cells contained the highest amount of glutathione, and in such cells c3Ado induced a significant increase in glutathione whereas the cytotoxic combination of c3Ado plus Hcy-tl decreased the amount of the reduced form. Quiescent confluent cells, which were less sensitive to the toxic effect of c3Ado, contained low glutathione, and under these conditions neither c3Ado alone nor in combination with Hcy-tl affected cellular glutathione. Remarkably, Hcy-tl alone induced an increase in glutathione in nondividing cells. These data suggest that homocysteine or some agents affecting homocysteine metabolism may modulate glutathione metabolism, but differently in dividing and nondividing cells.

1 This work was supported by grants from The Norwegian Society for Fighting Cancer and The Norwegian Cancer Society.

2 Fellow of the Norwegian Society for Fighting Cancer. To whom requests for reprints should be addressed, at Clinical Pharmacology Unit, Department of Pharmacology and Toxicology, University of Bergen, MFH-building, N-5021 Bergen, Norway.

3 Fellow of the Norwegian Cancer Society.

Received 5/ 3/88. Revised 9/21/88. Accepted 10/19/88.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.